Johnson & Johnson finalized its $1.25 billion acquisition of Yellow Jersey Therapeutics, a subsidiary of Switzerland-headquartered Numab Therapeutics, to secure the global rights to a treatment for ...

Paul Johnson has elected to step down after 11 seasons at Georgia Tech, ending a head coaching career that dates back to 1997 and has included success at both the FCS and FBS levels. In a statement ...